You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Improving treatment options and outcomes in fungal keratitis
SBC: TranZ Biosciences LLC Topic: NABSTRACT Fungal keratitisprimarily caused by CandidaFusariumor Aspergillus speciesis a leading cause of blindness among corneal diseasesAmphotericin BAmBremains the gold standard in the treatment of Candida keratitis and is also the fallback option for other corneal fungal infectionsAlthough widely used off label in ocular infectionsophthalmic AmB formulations are not available commerciallyThe com ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Ad-Hoc Ground Based Counter-Fire System
SBC: HYPERION TECHNOLOGY GROUP INC Topic: N142086This proposal addresses the development of a Command Post and Acoustic Listening Posts for performing detection and automatic geo-location and classification of transient acoustic sounds associated with the firing of weapons, especially rockets, mortars, and artillery and the corresponding munitions impacts. Key components of the system are rugged low-noise infrasound sensors, state-of-the-art aco ...
SBIR Phase II 2019 Department of DefenseNavy -
Lateral flow immunoassay for rapid diagnosis of tinea capitis and onychomycosis
SBC: DXDISCOVERY INC Topic: NIBIBTinea capitis (ringworm of the scalp) and onychomycosis (fungal nail infection) are infections that are most often caused by dermatophytes of the fungal genera Trichophyton and Microsporum. These two infections affect approximately 14 million people in the U.S. each year. Dermatophyte infections of the hair and nails are treated with oral antifungals for up to 12 weeks. Due to potential adverse ef ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need
SBC: STARTUP COMMUNITY INC Topic: AF191005There is a “race for technologyâ€Â and staying competitive is essential to keeping America safe. By providing warfighters with the most cutting edge technology and processes, the Air Force can continually innovate and evolve. Startup Community Inc (SCI) will help the USAF set the bar for engaging with those creating leading-edge technologies. Our goals are to see a future where: - The ...
SBIR Phase II 2019 Department of DefenseAir Force -
Non-Pyrotechnic Battlefield Effects Replication Using eSquibs
SBC: Digital Solid State Propulsion, Inc Topic: A18091Using electric solid propellant, DSSP has developed a non-pyrotechnic small arms fire simulator that will be optimized, enlarged and enhanced for Army live fire training applications. First, the new proprietary waterproof non-pyrotechnic propellant will be further characterized for long term use and function in eSquibs and similar devices. The eSquib muzzle flash effect will be enhanced as new var ...
SBIR Phase II 2019 Department of DefenseArmy -
Small UAS compatible Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) Sensors
SBC: NEVADA NANOTECH SYSTEMS, INC. Topic: AF18BT009Proposed herein are novel design methodologies to create sensors for chemical, biological, radiological, nuclear and/or explosive (CBRNE) detection aboard a Small Unmanned Aerial System (SUAS), as well as intelligent Bayesian-based plume analysis and source detection algorithms that offer capabilities for the Air Force above and beyond the state of the art. The assembled technical team of experts ...
STTR Phase I 2019 Department of DefenseAir Force -
Developing, Testing and Validating a Wearable Alcohol Biosensor
SBC: Clinitech, LLC Topic: 4501 PROJECT SUMMARY2 This application for a Phase II SBIR award extends the successful completion of Phase I and represents a 3 collaboration between Clinitech, LLC and McLean Hospital/Harvard Medical School to continue the4 development of a wearable biosensor for detecting alcohol in the interstitial fluid of humans. Excessive use of5 alcohol accounts for much of the public health burden related to ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Secure Cockpit-to-Ground Wireless Data Transfer
SBC: Ionotronics Corporation Topic: AF183013Current communication between a Fighter Pilot’s Helmet and the Cockpit is through a sophisticated cable. The requirements for the Helmet Heads Up Display and Video/Audio feed require Giga bps throughput. In this Phase I effort, a millimeter wave wireless system will be designed that supports end to end Gigabit Ethernet through a wireless link with the potential for 3.4 Gbps throughput. The ...
SBIR Phase I 2019 Department of DefenseAir Force -
Immunoassay for early diagnosis of mucormycosis
SBC: DXDISCOVERY INC Topic: NIAIDMucormycosis is one of the deadliest of the invasive fungal infections. Mucormycosis occurs most often in patients with hematological malignancies undergoing chemotherapy, patients who have received hematopoietic stem cell transplants or patients with diabetes mellitus. Improved diagnosis is the most frequently noted unmet need for management of the mucormycosis patient. Delays in treatment increa ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of a Process for GMP Production of Natural THC and CBD
SBC: ElSohly Laboratories, Incorporated Topic: R41Development Process for Production of Natural THC and CBD AbstractTetrahydrocannabinolTHCand cannabidiolCBDare two major constituents of the cannabis plant that have pharmacological properties with potential therapeutic value in several disease conditionsWhileTHC has already been in use clinically for two indicationsnausea and vomiting in cancer patients receiving chemotherapy and appetite stimula ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health